The trading price of Rallybio Corp (NASDAQ:RLYB) during today’s trading, the S&P 500 Index has current market day and closing at $0.46, 33.75% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $0.401 and $0.6048. In examining the 52-week price action we see that the stock hit a 52-week high of $1.54 and a 52-week low of $0.22. Over the past month, the stock has gained 34.23% in value.
Rallybio Corp, whose market valuation is $18.95 million at the time of this writing, is expected to release its quarterly earnings report on 2025-May-08. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest RLYB has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned RLYB a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Rallybio Corp (RLYB) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that RLYB’s price is currently 31.01% off the SMA20 and 37.77% off the SMA50. The RSI metric on the 14-day chart is currently showing 66.83, and weekly volatility stands at 5.76%. When measured over the past 30 days, the indicator reaches 13.35%. Rallybio Corp (NASDAQ:RLYB)’s beta value is currently sitting at -1.17.
To see how Rallybio Corp stock has been performing today in comparison to its peers in the industry, here are the numbers: RLYB stock’s performance was 33.75% at last check in today’s session, and -52.57% in the past year.
An evaluation of the daily trading volume of Rallybio Corp (NASDAQ:RLYB) indicates that the 3-month average is 200.92K. However, this figure has increased over the past 10 days to an average of 0.14.
Currently, records show that 41.61 million of the company’s shares remain outstanding. The insiders hold 52.22% of outstanding shares, whereasinstitutions hold 29.12%. The stats also highlight that short interest as of 2025-06-13, stood at 0.33 million shares, resulting in a short ratio of 1.3 at that time. From this, we can conclude that short interest is 98.00 of the company’s total outstanding shares. It is noteworthy that short shares in June were down slightly from the previous month’s figure, which was 0.36 million. However, since the stock’s price has seen -64.43% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
